199 related articles for article (PubMed ID: 27048212)
1. How I vaccinate blood and marrow transplant recipients.
Carpenter PA; Englund JA
Blood; 2016 Jun; 127(23):2824-32. PubMed ID: 27048212
[TBL] [Abstract][Full Text] [Related]
2. [Vaccination].
Graubner UB; Liese J; Belohradsky BH
Klin Padiatr; 2001 Sep; 213 Suppl 1():A77-83. PubMed ID: 11577366
[TBL] [Abstract][Full Text] [Related]
3. [Post-transplantation vaccination of bone-marrow transplant recipients].
Adell C; Bayas JM; Vilella A; Perales M; Vidal J; Bertran MJ; Rojano X; Asenjo MA
Med Clin (Barc); 2002 Oct; 119(11):405-9. PubMed ID: 12381273
[TBL] [Abstract][Full Text] [Related]
4. A national survey of immunization practices following allogeneic bone marrow transplantation.
Henning KJ; White MH; Sepkowitz KA; Armstrong D
JAMA; 1997 Apr; 277(14):1148-51. PubMed ID: 9087470
[TBL] [Abstract][Full Text] [Related]
5. Vaccination of adults 65 years of age and older with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Boostrix(®)): results of two randomized trials.
Weston WM; Friedland LR; Wu X; Howe B
Vaccine; 2012 Feb; 30(9):1721-8. PubMed ID: 22212127
[TBL] [Abstract][Full Text] [Related]
6. Are parental vaccine safety concerns associated with receipt of measles-mumps-rubella, diphtheria and tetanus toxoids with acellular pertussis, or hepatitis B vaccines by children?
Bardenheier B; Yusuf H; Schwartz B; Gust D; Barker L; Rodewald L
Arch Pediatr Adolesc Med; 2004 Jun; 158(6):569-75. PubMed ID: 15184221
[TBL] [Abstract][Full Text] [Related]
7. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
America Academy of Pediatrics Commitee on Infectious Diseases
Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
[TBL] [Abstract][Full Text] [Related]
8. A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vaccine in 3 and 4-year-old healthy children in the UK.
Marlow R; Kuriyakose S; Mesaros N; Han HH; Tomlinson R; Faust SN; Snape MD; Pollard AJ; Finn A
Vaccine; 2018 Apr; 36(17):2300-2306. PubMed ID: 29576304
[TBL] [Abstract][Full Text] [Related]
9. Reimmunization after bone marrow transplantation--current recommendations and perspectives.
Machado CM
Braz J Med Biol Res; 2004 Jan; 37(1):151-8. PubMed ID: 14689057
[TBL] [Abstract][Full Text] [Related]
10. Effect of Tdap upon antibody response to meningococcal polysaccharide when administered before, with or after the quadrivalent meningococcal TT-conjugate vaccine (coadministered with the 13-valent pneumococcal CRM197-conjugate vaccine) in adult Hajj pilgrims: A randomised controlled trial.
Tashani M; Alfelali M; Barasheed O; Alqahtani AS; Heron L; Wong M; Rashid H; Findlow H; Borrow R; Booy R
Vaccine; 2018 Jul; 36(29):4375-4382. PubMed ID: 29880243
[TBL] [Abstract][Full Text] [Related]
11. Vaccination in Chronic Kidney Disease.
Reddy S; Chitturi C; Yee J
Adv Chronic Kidney Dis; 2019 Jan; 26(1):72-78. PubMed ID: 30876620
[TBL] [Abstract][Full Text] [Related]
12. Response to measles, mumps and rubella vaccine in paediatric bone marrow transplant recipients.
King SM; Saunders EF; Petric M; Gold R
Bone Marrow Transplant; 1996 Apr; 17(4):633-6. PubMed ID: 8722367
[TBL] [Abstract][Full Text] [Related]
13. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP).
Broder KR; Cortese MM; Iskander JK; Kretsinger K; Slade BA; Brown KH; Mijalski CM; Tiwari T; Weston EJ; Cohn AC; Srivastava PU; Moran JS; Schwartz B; Murphy TV;
MMWR Recomm Rep; 2006 Mar; 55(RR-3):1-34. PubMed ID: 16557217
[TBL] [Abstract][Full Text] [Related]
14. Antibody responses to vaccinations given within the first two years after transplant are similar between autologous peripheral blood stem cell and bone marrow transplant recipients.
Gandhi MK; Egner W; Sizer L; Inman I; Zambon M; Craig JI; Marcus RE
Bone Marrow Transplant; 2001 Oct; 28(8):775-81. PubMed ID: 11781630
[TBL] [Abstract][Full Text] [Related]
15. Immunization of children after solid organ transplantation.
Lopez MJ; Thomas S
Pediatr Clin North Am; 2003 Dec; 50(6):1435-49, ix-x. PubMed ID: 14710786
[TBL] [Abstract][Full Text] [Related]
16. Adult immunizations: update on recommendations.
Pham H; Geraci SA; Burton MJ;
Am J Med; 2011 Aug; 124(8):698-701. PubMed ID: 21658665
[TBL] [Abstract][Full Text] [Related]
17. Vaccination of solid organ transplant candidates and recipients: Guidelines from the American society of transplantation infectious diseases community of practice.
Danziger-Isakov L; Kumar D;
Clin Transplant; 2019 Sep; 33(9):e13563. PubMed ID: 31002409
[TBL] [Abstract][Full Text] [Related]
18. Immunization Practices of U.S. Obstetrician/Gynecologists for Pregnant Patients.
O'Leary ST; Riley LE; Lindley MC; Allison MA; Crane LA; Hurley LP; Beaty BL; Brtnikova M; Collins M; Albert AP; Fisher AK; Jiles AJ; Kempe A
Am J Prev Med; 2018 Feb; 54(2):205-213. PubMed ID: 29246674
[TBL] [Abstract][Full Text] [Related]
19. A clinical analysis of gelatin allergy and determination of its causal relationship to the previous administration of gelatin-containing acellular pertussis vaccine combined with diphtheria and tetanus toxoids.
Nakayama T; Aizawa C; Kuno-Sakai H
J Allergy Clin Immunol; 1999 Feb; 103(2 Pt 1):321-5. PubMed ID: 9949325
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity and safety of a tetanus toxoid, reduced diphtheria toxoid and three-component acellular pertussis vaccine in adults 19-64 years of age.
Blatter M; Friedland LR; Weston WM; Li P; Howe B
Vaccine; 2009 Jan; 27(5):765-72. PubMed ID: 19041352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
